Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans. by Comas, Iñaki et al.
Comas, Inaki; Coscolla, Mireia; Luo, Tao; Borrell, Sonia; Holt, Kathryn
E; Kato-Maeda, Midori; Parkhill, Julian; Malla, Bijaya; Berg, Ste-
fan; Thwaites, Guy; Yeboah-Manu, Dorothy; Bothamley, Graham;
Mei, Jian; Wei, Lanhai; Bentley, Stephen; Harris, Simon R; Nie-
mann, Stefan; Diel, Roland; Aseffa, Abraham; Gao, Qian; Young,
Douglas; Gagneux, Sebastien (2013) Out-of-Africa migration and Ne-
olithic coexpansion of Mycobacterium tuberculosis with modern hu-
mans. NATURE GENETICS, 45 (10). 1176-U311. ISSN 1061-4036
DOI: https://doi.org/10.1038/ng.2744
Downloaded from: http://researchonline.lshtm.ac.uk/4651858/
DOI: 10.1038/ng.2744
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by-nc-nd/2.5/
Out-of-Africa migration and Neolithic co-expansion of 
Mycobacterium tuberculosis with modern humans
Iñaki Comas1,2,@, Mireia Coscolla3,4,*, Tao Luo5,*, Sonia Borrell3,4, Kathryn E. Holt6, Midori 
Kato-Maeda7, Julian Parkhill8, Bijaya Malla3,4, Stefan Berg9, Guy Thwaites10, Dorothy 
Yeboah-Manu11, Graham Bothamley12, Jian Mei13, Lanhai Wei14, Stephen Bentley8, Simon 
R. Harris8, Stefan Niemann15, Roland Diel16, Abraham Aseffa17, Qian Gao5,@, Douglas 
Young18,19,#, and Sebastien Gagneux3,4,#,@
1Genomics and Health Unit, Centre for Public Health Research (CSISP-FISABIO), 46020 
Valencia, Spain 2CIBER in Epidemiology and Public Health, Spain 3Department of Medical 
Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, 4002 Basel, 
Switzerland 4University of Basel, 4002 Basel, Switzerland 5Key Laboratory of Medical Molecular 
Virology, Institutes of Biomedical Sciences and Institute of Medical Microbiology, Shanghai 
Medical College, Fudan University, Shanghai 200032, China 6Department of Biochemistry and 
Molecular Biology and Bio21 Molecular Science and Biotechnology Institute, The University of 
Melbourne, 3010 Victoria, Australia 7Division of Pulmonary and Critical Care Medicine, University 
of California San Francisco, 94143 San Francisco, USA 8Pathogen Genomics, The Wellcome 
Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK 
9TB Research Group, Veterinary Laboratories Agency, Weybridge, New Haw, Addlestone, Surrey 
KT15 3NB, UK 10Department of Infectious Disease/Centre for Clinical Infection and Diagnostics 
Research, King's College London, SE1 1UL, United Kingdom 11Noguchi Memorial Institute for 
Medical Research, University of Ghana, LG 581 Legon, Ghana 12Department of Respiratory 
Medicine, Homerton University Hospital, London E9 6SR, UK 13Department of Tuberculosis 
Control, Shanghai Municipal Center for Disease Control and Prevention, 1380 W Zhongshan 
Road, Shanghai, 200336, China 14Ministry of Education Key Laboratory of Contemporary 
Anthropology, School of Life Sciences and Institutes of Biomedical Sciences, Fudan University, 
200433 Shanghai, China 15Molecular Mycobacteriology, Research Center Borstel, 23845 Borstel, 
Germany 16Institute for Epidemiology, Schleswig-Holstein University Hospital, Niemannsweg 11, 
Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, 
subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
@Correspondents and request for materials should be addressed to I.C. (inaki.comas@uv.es), Q.G. (qgao99@yahoo.com) or S.G. 
(sebastien.gagneux@unibas.ch).
*these authors contributed equally to this work
#these authors jointly supervised this work
Accession codes
The sequencing reads of those strains that are not already publicly available can be found under study number ERP001731. For a 
complete list of strains sequenced in this study refer to Supplementary Table 1.
The authors declare no competing financial interests.
Author contribution
IC, QG, DY and SG designed and supervised the study. MC, SBO, KEH, MK-M, JP, BM, SBO, GT, DY-M, GB, JM, LW, SBE, SH, 
SN, RD, AA, QG and SG provided MTBC strains/reagents. JP, SBE, and SH contributed to the genome sequencing. IC, MC and TL 
analysed the data. IC, MC, TL, SBO, KEH, JP, SB, GT, DY-M, SBE, SH, SN, AA, QG, DY and SG contributed to the manuscript 
writing. All authors read and approved the manuscript.
HHS Public Access
Author manuscript
Nat Genet. Author manuscript; available in PMC 2014 April 01.
Published in final edited form as:
Nat Genet. 2013 October ; 45(10): 1176–1182. doi:10.1038/ng.2744.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
24105 Kiel, Germany 17Armauer Hansen Research Institute, P.O. Box 1005 Addis Ababa, 
Ethiopia 18MRC National Institute for Medical Research, Mill Hill, London, NW7 1AA, UK 
19Division of Medicine and Centre for Molecular Microbiology and Infection, Imperial College 
London, London SW7 2AZ, UK
Abstract
Tuberculosis caused 20% of all human deaths in the Western world between the 17th and 19th 
centuries, and remains a cause of high mortality in developing countries. In analogy to other 
crowd diseases, the origin of human tuberculosis has been associated with the Neolithic 
Demographic Transition, but recent studies point to a much earlier origin. Here we used 259 
whole-genome sequences to reconstruct the evolutionary history of the Mycobacterium 
tuberculosis complex (MTBC). Coalescent analyses indicate that MTBC emerged about 70 
thousand years ago, accompanied migrations of anatomically modern humans out of Africa, and 
expanded as a consequence of increases in human population density during the Neolithic. This 
long co-evolutionary history is consistent with MTBC displaying characteristics indicative of 
adaptation to both low- and high host densities.
Tuberculosis killed one in five adults in Europe and North-America between the 17th and 
19th centuries1, and remains today a cause of high morbidity and mortality in much of the 
developing world2. Infectious diseases of humans can be divided into two broad categories3. 
Crowd diseases are generally highly virulent and depend on high host population densities to 
maximize pathogen transmission and reduce the risk of pathogen extinction through 
exhaustion of susceptible hosts4. Many crowd diseases emerged during the Neolithic 
Demographic Transition (NDT) starting around ten thousand years ago (kya), as the 
development of animal domestication increased the likelihood of zoonotic transfer of novel 
pathogens to humans, and agricultural innovations supported increased population densities 
that helped sustain the infectious cycle3. In contrast, older human infections are often 
characterized by slow progression to disease, sometimes involving reactivation after many 
years of latent or asymptomatic infection; these characteristics have been proposed to reflect 
adaptation to low host population densities by allowing repletion of the reservoir of 
susceptible individuals5. Tuberculosis is reminiscent of a typical crowd disease in killing up 
to 50% of individuals when left untreated3,6, and having evolved a mode of aerosol 
transmission that is promoted by high host densities. However, tuberculosis also displays a 
pattern of chronic progression, latency and reactivation that is characteristic of a pre-NDT 
disease7. Human tuberculosis was traditionally believed to have originated from animals4, 
but more recent phylogenetic analyses of MTBC have suggested that strains adapted to 
cause tuberculosis in animals diverged from the major human strains before NDT8–13. 
Moreover, human-associated MTBC is an obligate human pathogen with no known animal 
or environmental reservoir, suggesting that changes in human demography are likely to 
affect the evolution of MTBC. Here we used a population genomics approach to explore the 
evolutionary history of human MTBC, with a particular focus on the impact of changing 
host population sizes over time. Our results suggest a model that allows reconciliation of the 
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apparent discrepancy between MTBC features characteristic of crowd diseases versus those 
indicative of adaptation to low host densities.
The global diversity of human-adapted MTBC
We generated the genome sequences of 220 strains representative of the global diversity of 
MTBC (Supplementary Table 1) and 39 additional strains corresponding to the lineage 2 
"Beijing" family. In the global dataset, after excluding repetitive and mobile elements, we 
identified 34,167 polymorphic sites (SNPs) (Supplementary Table 2), which we used to 
reconstruct the phylogenetic relationships between these strains (Fig. 1A). This genome-
based phylogeny was congruent with previous phylogenies based on other markers and 
resolved seven major lineages, with animal-adapted strains clustering together with the 
strains from Lineage 68. The phylogeny includes the recently described Lineage 7, which to 
date has only been observed in Ethiopia or recent Ethiopian emigrants14. Principal 
component analysis confirmed all main MTBC lineages, and highlighted the close 
phylogenetic relationship between the Eurasian Lineages 2, 3 and 4. These three lineages 
have collectively been referred to as evolutionarily “modern” (Fig. 1B) in the past, because 
of their comparably more derived position on the MTBC phylogeny and because they are 
thought to have spread more recently8,11. The maximum genetic distance between any two 
strains was 2,188 SNPs and involved a human and an animal strain, and 1,856 SNPs when 
only human clinical isolates were considered. Only 387 (1.1%) of the SNPs were 
homoplastic. Homoplasy can arise as a consequence of false-positive SNP calls, because of 
positive selection, recurrent mutations or because of recombination as recently suggested15. 
However, the fact that only 1.1% of the sites are homoplastic supports the view that the 
population structure of MTBC is largely clonal with little ongoing recombination occurring 
between strains16,17.
African origin and co-divergence of MTBC with modern humans
Several studies have proposed an African origin for MTBC8,10,12. We decided to formally 
test this hypothesis using our new whole-genome data. We used three independent 
phylogeographical analyses to determine the likely geographic origin of the most recent 
common ancestor of MTBC. Two different Bayesian analyses identified Africa as the most 
likely origin of MTBC, with East- and West Africa showing a combined posterior 
probability of 90% and 67%, respectively (Supplementary Figs. 1, 2, and 3). Similarly, a 
Maximum Parsimony approach predicted 100% probability of an African origin. Taken 
together, these data support an African origin for MTBC.
Next we sought to determine the putative age of the association between MTBC and its 
human host. Given that human-adapted MTBC is limited to humans, and both anatomically 
modern humans and MTBC originated in Africa, we tested whether MTBC and humans 
might have diverged in parallel; this would be particularly likely if the association between 
the two predates the NDT, as previously postulated8,10,12. To explore this possibility, we 
first compared our new MTBC phylogeny to a corresponding tree constructed from 4,955 
mitochondrial genomes representative of the main human haplogroups (Supplementary 
Table 3)18. We observed striking similarities (Figs. 1C and 1D). In both cases, the early 
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branching clades are found exclusively in Africa. Moreover, the trichotomy formed by 
branching of the Out-of-Africa M and N mitochondrial macro-haplogroups from the L3 
African source population is mirrored in the MTBC phylogeny by a similar relationship 
between Lineage 1, Eurasian Lineages 2/3/4, and the African Lineages 5 and 6. In addition 
to this qualitative similarity, comparison of the most common mitochondrial haplogroups 
with the most frequent MTBC lineages in the same country revealed a strong quantitative 
association (Parsimony Score and Association Index tests; P < 0.01 in all cases) 
(Supplementary Fig. 4, Supplementary Table 5 and Supplementary Table 6). Taken together, 
these data are consistent with MTBC evolving in parallel with its human host.
Age of the association of MTBC and humans
The similarities in tree topology and phylogeographic distribution suggest that MTBC 
already infected the early human populations of Africa. To further explore the association 
between MTBC and its human host, we tested for possible imprints of ancient human 
divergence times on the main phylogenetic lineages of MTBC using a Bayesian approach19. 
Several approaches have been used to date bacterial phylogenies (see refs. 20–22 for some 
examples). Unfortunately, none of these were applicable here because of the following 
reasons. First, although ancient DNA has been used to study the evolutionary history of 
other bacteria20, and similar studies have been performed in tuberculosis in the past23, no 
relevant whole-genome data are currently available from ancient DNA of MTBC strains. 
Second, although a mutation rate for MTBC has recently been estimated based on a 
macaque infection model and molecular epidemiological data24,25, it is well known that 
such short-term mutation rates cannot easily be extrapolated to long-term substitution rates 
relevant for the time-scale discussed here26,27. Third, and related to the previous point, 
although the isolation dates of some of the strains included in our analysis were known, at 
best they would allow calculation only of a short-term mutation rate. Moreover, when 
performing a tip-to-date analysis of those strains (N = 49), we found that in contrast to 
several other bacterial species21,28–30, no significant correlation between isolation time and 
phylogenetic divergence exists in MTBC (correlation coefficient = 0.047).
Because of these limitations, we used an alternative approach to date our MTBC phylogeny. 
Specifically, we used as initial calibration points several key dates in human evolution. We 
tested three alternative models in which the coalescent time of the most basal MTBC 
Lineages 5 and 6 was calibrated against: i) the emergence of anatomically modern humans 
185 +/−20 kya (MTBC-185)31, ii) the coalescent time of the L3 mitochondrial haplogroup 
70 +/−10 kya (MTBC-70)32, and iii) the beginning of the NDT 10 +/−2 kya (MTBC-10)3 
(Table 1). We compared the timing of the branching points predicted by each of the models 
with estimated dates of known events in human history. A recent model based on human 
whole-genome analyses suggests that the global dispersal of modern humans occurred 
through two major waves; an initial eastern dispersal around the Indian Ocean starting 62–
75 kya, and a later dispersal into Eurasia 25–38 kya33. Our MTBC-70 model showed a 
striking correlation with these human migration events by dating a first split of Lineage 1 at 
67 kya (95% highest probability density (HPD): 48–88 kya) coinciding with the first wave 
of human migration31, and a second split at 46 kya (95% HPD: 31–61 kya) matching the 
later dispersal throughout Eurasia (Fig. 2a, Supplementary Fig 5)34,35. Coalescent dates for 
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the branch leading to Lineages 4 and 2 in the MTBC-70 model (30–46 kya and 32–42 kya, 
respectively) show a good correlation with archaeological evidence of presence of modern 
humans in Europe35 and East Asia36. In contrast, our alternate model MTBC-185 postulates 
initial branching of Out-of-Africa lineages as early as 126–174 kya when focusing on the 
branch leading to 'modern' strains (Supplementary Fig. 6), which would suggest the global 
dispersal of MTBC preceded that of anatomically modern humans. MTBC-10, by definition, 
implies global dispersal within the last 10 ky (Supplementary Fig. 7). While MTBC has 
been spread by trade and conquest in recent centuries8, the pattern of this dispersal does not 
match the phylogeographic distribution discussed above. Finally, a fourth model 
(MTBC-65) using the coalescent time of mitochondrial haplogroup M as a calibration time-
point for MTBC Lineage 1 generated very similar results to MTBC-70 (Table 1). In 
summary, our phylogenetic analysis based on a 70 ky timeframe shows that MTBC has been 
infecting humans at least for the last 70 ky.
Neolithic co-expansion of MTBC and humans
All the data presented so far strongly support the notion that human tuberculosis indeed 
predates NDT. How then could the features of tuberculosis typical of crowd diseases have 
arisen? To address this question, we used Bayesian skyline plots to estimate the changes in 
effective population size over time of the pathogen and human populations19. Our MTBC 
dataset revealed a main signal of population size increase starting 10 kya to 2.5 kya (Fig. 
2B), suggesting that the expansion of MTBC occurred as a consequence of the increase in 
population densities that followed the establishment of first human settlements during the 
NDT37, and not just because of a general increase in the total number of humans peopling 
the planet at the time. To test if the human population dynamics around that period coincide 
with that of the MTBC we used a dataset previously described to maximize the information 
on human demographics during the Neolithic (Supplementary Table 6)38. The resulting 
skyline plot shows a Neolithic expansion of humans around 4–8 kya (Supplementary Fig. 8) 
coinciding with that of MTBC (Spearman R = 0.99, p <0.00001; Fig. 2B, Supplementary 
Fig. 8). Taken together, these findings indicate that the Neolithic contributed to the success 
of MTBC, not by enhancing the likelihood of zoonotic transfer to humans as previously 
proposed, but because of a combined increase in host population size and density.
The evolutionary history of MTBC at a regional scale
To analyze MTBC evolution at a regional level, we focused on Lineage 2, which includes 
the “Beijing” family of strains. These strains have received particular attention because of 
their hyper-virulence in laboratory models, their recent dissemination in human populations, 
and their association with drug resistance39. Supplementing our global diversity set with an 
additional 39 Lineage 2 genomes from China, we observed a strong correlation between 
skyline plots derived from the Lineage 2 genomes and a set of human mitochondrial 
genomes enriched with haplogroups from East Asia of likely origin just before, during or 
after the Neolithic (Spearman R = 0.97, p <0.001; Fig. 3A, Supplementary Fig. 9). 
MTBC-70 dating for Lineage 2 is consistent with an initial arrival coincident with 
archeological evidence of anatomically modern humans in East Asia36 (32–42 kya, 
Supplementary Fig. 5), a first expansion (6–11 kya, Figs. 3B and 3C) alongside the 
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emergence of agriculture in China 8 kya40, and a subsequent main expansion of the 
"Beijing" strains (3–5 kya, Supplementary Fig. 9) coinciding with the spread of agriculture 
to neighbouring regions (Figs. 3B and 3C)37.
In summary, our data on the global and regional expansion of MTBC during the NDT 
supports the view that while NDT was not the only period leading to strong increases in 
human population sizes, it was the period where in addition to human population growth, the 
densities of human populations increased following the first establishment of permanent 
human settlements. Hence, in addition to providing a springboard for global domination by 
modern humans, NDT was also central to the success of MTBC by generating growing 
numbers of susceptible hosts living in increasingly crowded conditions.
Concluding remarks
The common origin in Africa, the congruence in phylogeography, and the dating of major 
branching events, lead us to conclude that MTBC has been co-evolving with anatomically 
modern humans for tens of thousands of years. The marked expansion of MTBC during the 
NTD, but not during earlier human expansion events41,42, suggests that the success of this 
pathogen was primarily driven by increases in human host density, which is typical of crowd 
diseases. However, the striking match between the MTBC and human mitochondrial 
phylogenies supports a much older association between MTBC and its host, and suggest that 
carriage of MTBC was ubiquitous in hunter-gatherer populations migrating out of Africa 
well before NDT. The fidelity of this match is surprising. Considering their vulnerability and 
small numbers (some of today’s hunter-gatherers live in groups of 20 or less43), it might 
have been anticipated that tuberculosis disease would have had a significant detrimental 
impact on these groups, and might therefore have precipitated its own extinction. In fact, the 
correspondence between MTBC phylogeny with early human migration is strikingly similar 
to that observed with low virulence Helicobacter pylori44. Perhaps latent infection with 
MTBC imparted some degree of immunity against more lethal pathogens encountered in the 
new environment or in contact with archaic human populations? The ongoing analyses of 
the human microbiota highlight the fuzzy boundaries between commensalism and 
pathogenecity during health and disease45. A recent study has suggested that co-infection 
with H. pylori might protect against active tuberculosis disease46. Conversely, whether 
latent tuberculosis infection protects against gastric ulcers or stomach cancer caused by H. 
pylori in individuals infected with both bacteria is unknown but an intriguing possibility. In 
such a case, a positive feedback between both infections would result in an asymptomatic 
individual benefiting from being infected by both bacterial species.
Alternatively, one could think of a model in which early populations carried the infection in 
a less virulent form, with transmission sustained by reactivation disease in elderly 
individuals after reproductive age. The possibility that disease characteristics might have 
changed over time as different MTBC populations were selected in different human 
societies may help to explain current epidemiological trends associated with increased 
dissemination of the "Beijing" family of MTBC39, and decreased rates of disease caused by 
evolutionarily “ancient” lineages of MTBC47. In addition to changes in population density, 
it can be anticipated that the pathology of tuberculosis during NDT would have been 
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influenced by co-infections with novel crowd diseases and by variations in key nutrients 
such as vitamin D48. Similarly, it is important to consider the possibility of reciprocal 
adaptive changes to the human genome as a result of prolonged co-evolution with MTBC49.
In this study, we have compared MTBC phylogenic diversity to human diversity inferred 
from mitochondrial genome data. One advantage of using mitochondrial data is that it has 
been used extensively to study recent human evolution in the past. Furthermore, such data is 
available from almost any region of the world, and there is a large body of work studying 
human migrations based on the distribution of mitochondrial haplogroups. However, 
mitochondrial DNA is also limited in that it contains little phylogenetic information, and the 
existing data sets suffer from potential sampling bias. Increasingly, new DNA sequencing 
technologies are paving the way for studies of human diversity based on whole genomes33. 
Hence in the context of a pathogen like MTBC, future studies should be based on paired 
human- and bacterial whole-genome information collected prospectively. Such an integrated 
approach will allow investigating the molecular determinants of host-pathogen co-evolution 
in human tuberculosis and other diseases.
The accumulation of more than 30 thousand SNPs by human MTBC strains over the 
proposed timeframe of 70 thousand years corresponds to a long-term genome-wide 
substitution rate of 2.58 × 10−9 substitutions per site per year (95% HPD 1.66 × 10−9 to 2.89 
× 10−9, Table 1). This is much lower than recent estimates of short-term substitution rates in 
experimental models and human outbreaks24,25. A decrease in substitution rates measured 
over increasing time intervals is a common feature of phylogenetic analyses27, and an 
exponential decrease is observed in the substitution rate with time when we pool our data 
with other similar genome-based studies published recently (correlation coefficient = 
−0.9614, P < 0.0001, Figure 4). Fixation or removal of single nucleotide changes by natural 
selection can contribute to this phenomenon, though retention of a high proportion of 
nonsynonymous mutations suggests that this has had a low impact on MTBC8. Alternative 
mechanisms to account for the reduction of genetic diversity over long timescales include 
serial founder effects linked to sequential expansions of human subpopulations and their 
associated pathogenic and commensal microbial flora50.
In conclusion, we propose that MTBC has been a constant companion of anatomically 
modern humans during our evolution and global dissemination over the last 70 thousand 
years. Furthermore, MTBC has been able to adapt to changing human populations. 
Exploration of changes that have occurred in this interaction over time may help predict 
future patterns of disease and to design rational strategies to bring an end to this historic 
partnership.
Online methods
Datasets
1. MTBC datasets—We have analyzed a total of 259 MTBC strains (including one 
Mycobacterium canettii strain used as outgroup). We used two different strains sets for 
different aspects of the analyses:
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- Global MTBC dataset (n = 220): This dataset represents a global collection of 
MTBC clinical strains covering all the known phylogenetic lineages of MTBC 
and including representatives from 46 countries. In addition, three strains from 
the animal-adapted lineage (including one strain of the Mycobacterium bovis 
BCG vaccine) were included as reference, and one strain of Mycobacterium 
canettii, which was used as the outgroup. More detailed information can be 
found in Supplementary Table 1.
- MTBC Lineage 2 enriched dataset (n = 75): To explore the evolution of 
MTBC in a regional setting, we extended our collection of 36 MTBC strains 
from Lineage 2 with an additional 39 strains which represent the population 
diversity of Lineage 2 in China based on standard genotyping (Supplementary 
Table 1).
Illumina reads of the strains described in this study have been deposited under 
the project number ERP001731.
2. Human mitochondrial dataset—For the comparison with human genetic diversity, 
we analyzed large datasets of complete mitochondrial genomes (described below). There are 
limitations inherent to mtDNA. First, estimating the most frequent mtDNA haplogroup in a 
particular country is always difficult and sampling-dependent. Second, mtDNA harbours 
limited phylogenetic information. However, the reasons to focus on a mitochondrial marker 
rather than on a chromosomal marker are 1) availability of information for most of the 
regions/countries in terms of mtDNA haplogroup frequencies and 2) the possibility to 
compare with previous published studies dealing with human mtDNA haplogroups, human 
migrations and population dynamics. We used three different sets of human mitochondrial 
genomes that were available in public repositories. These are listed in Supplementary Tables 
3, 6 and 7.
- Global reference dataset of human mtDNAs (n = 4,955): This dataset is a 
compilation of most of the publicly available human mitochondrial (mtDNA) 
genomes for which the haplogroup has been determined18. This dataset includes 
representatives of most known human mitochondrial macro-haplogroups and 
derived haplogroups.
- Neolithic population expansion dataset of human mtDNAs (n = 423): This 
second dataset is derived from the dataset reported by Gignoux 201138, and 
includes selected representative haplogroups known to have their origin either 
before, during or shortly after the Neolithic period, and therefore maximized to 
detect signatures of population expansions around that period that could be 
obscure by earlier expansion events.
- East Asia enriched Neolithic dataset of human mtDNAs (n = 72): As for 
MTBC Lineage 2, we complemented the dataset for East Asia by adding any 
newly published human mitochondrial genome from the mtDNA haplogroups of 
interest (B4a1, F1a1, E1a, E1b).
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Sequencing of MTBC strains
The majority of MTBC strains were sequenced during the present project at different 
sequencing centres (GATC, Germany; Wellcome Trust Sanger Institute, United Kingdom; 
and Southern Genome Center, China); a few additional sequences were retrieved from 
publicly available databases. MTBC DNA was extracted using standard procedures. Single- 
or Paired-end multiplexed Illumina sequencing was performed as described previously51. 
Briefly, sequencing was performed on a HiScanSQ instrument and TruSeq SBS Kit – HS 
chemistry (Illumina, USA) to generate between 51 and 100 bases long sequencing reads 
depending on the strain. Average genome coverage was 146.5 of the reference genome (the 
strain-specific genome coverage is shown in Supplementary Table 1).
Mapping Illumina sequencing reads and SNP calling
Sequencing reads of each MTBC strain were mapped to the inferred most recent common 
ancestor (MRCA) of MTBC as previously determined52 (the sequence of the MTBC MRCA 
can be found as fasta formatted as part of the Supplementary information). We used two 
mapping approaches; the un-gapped MAQ53 algorithm and the Burrows-Wheeler algorithm 
described in BWA54 and MAQ SNP caller and Samtools55 to generate two different lists of 
SNPs. We kept those polymorphic positions called by both approaches. For a complete 
description of the SNP calling procedure and annotation of the positions see Supplementary 
Text as well as Supplementary Figure 10 for a workflow of the SNP calling procedure.
Phylogenetic and principal component analyses
Human mtDNA datasets were obtained from the database of variant positions used by Behar 
et al.18. For the population expansion dataset of human mtDNA during Neolithic, the 
relevant accession numbers described in Gignoux et al.38 were downloaded and the genomes 
aligned using the ClustalW56 implementation in BioEdit package57 followed by manual 
curation. We removed the poorly aligned region known as D-loop and kept the polymorphic 
sites for subsequent phylogenetic and coalescent analyses. For the MTBC datasets, we used 
the variable positions for all downstream analyses. In both cases we applied phylogenetic 
distance as well as maximum-likelihood methods. For a complete description of the 
phylogenetic analyses, the identification of homoplastic sites and the principal component 
analysis of the SNPs used see Supplementary Text.
Phylogeographic analyses
For the phylogeographic analyses we used the BSSVS model implemented in BEAST 1.658. 
We also used RASP59 that implements both Bayesian and parsimony approaches to analyze 
the ancestral geographic ranges of MTBC lineages. We sub-divided the world map into 
seven broad geographic areas and used them as a proxy for the most likely origin of each 
strain (see Supplementary Fig. 1 for the world sub-division and Supplementary Table 1 for 
patient origin). We used broad geographic areas instead of the exact location because the 
high number of locations to consider, and hence the exchange rates to estimate, would be 
unmanageable if using all individual countries. Predefined geographic areas were introduced 
for each MTBC strain according to the patient’s country of origin. See Supplementary Text 
for a complete description of the settings of the different phylogeographic analyses.
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MTBC-mtDNA association test
We tested the hypothesis that modern Lineages 2, 3 and 4, Lineage 1 and the African 
Lineages 5 and 6 are associated with the N, M and L human mtDNA lineages. To this end, 
we assigned for each MTBC strain from a given country an mtDNA haplogroup according 
to the frequency of the haplogroup in that country based on a review of the published 
literature (Supplementary Table 5). Only the two most frequent MTBC lineages of a country 
and the two most frequent mtDNA haplogroups were considered, unless only one MTBC 
lineage occurred in the country, in which case it was assigned to the most frequent mtDNA 
of the country (Supplementary table 4). We used BaTs (Bayesian Tip-association 
significance testing) 60 to test whether the main lineages of MTBC for each country tend to 
be associated with a particular human mtDNA macro-haplogroup (L, M, N) or haplogroup 
(A, B, D, E, F, G, H, K, L, M, R, U) (Supplementary Fig. 4 and Supplementary Tables 4 and 
5). For the tests we assumed that there was no MTBC lineage that corresponded to the L0, 
L1, L2 and L4 human mitochondrial lineages based on the fact that no Lineage 5 or 6 strains 
are found outside of West Africa where human mitochondrial L3 have the highest 
frequency31. However even when we introduce L0, L1, L2 and L4 the results of the tests do 
not change. BaTs implements two association indexes, the Parsimony Score (PS) that 
quantifies the number of state changes in the phylogeny (low number indicates high 
clustering of states) and the Association Index (AI) that looks at internal nodes and records 
the most frequent state in the taxa downstream of the node. A statistical test was carried out 
by reshuffling the various states across the phylogeny. Given the constrained 
phylogeographic distribution of Lineage 5 and 6 (i.e. Mycobacterium africanum) to West 
Africa and their basal but close position to all the "Out-of-Africa" lineages, these M. 
africanum lineages correlate best with the human mitochondrial L3 haplogroup which shows 
remarkable similarities.
BEAST analyses
We used BEAST v. 1.619 to date the evolutionary events and population dynamics of MTBC 
and the human mtDNA haplogroups. BEAST implements the joint sampling of the posterior 
distribution of different evolutionary parameters like the substitution rate or the population 
size under a coalescent framework. In all cases, we used a skyline prior to look for changes 
of population size over time. For MTBC, we used two datasets: to explore different dating 
hypotheses, we used the complete MTBC dataset, a total of 216 strains excluding the 
outgroup (M. canettii) and the animal strains. We used an uncorrelated log-normal 
distribution for the substitution rate in all cases. We imposed different prior values to the 
coalescent times of the Lineages 5 and 6 according to plausible time estimates. Because no 
fossil records or good substitution rate estimates are available for MTBC, we used this 
approach as a way to narrow down the origin and age of the extant strains of MTBC. We 
imposed normal distributions in the coalescent time of Lineages 5 and 6, as time estimates 
for mitochondrial haplogroups are usually given in coalescent times and not times of 
splitting events between groups: 185 (+/− 20kya), 70 (+/− 10kya) and 10 (+/−2kya). We also 
added as a second anchor point the split of MTBC Lineage 1 with a normal prior of 65 +/− 
10 kya, based on the co-incident geographic distribution of Lineage 1 with human 
mitochondrial macro-haplogroup M. Similar approaches were followed to analyzed the 
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mtDNA datasets where we used both a molecular clock approach (by specifying a published 
substitution rate31) and a dating approach (by assuming the height of the phylogeny 
distributed normally around 185 kya as a mean +/− 20 kya). Both approaches yielded similar 
results, and we report the results for the dating analyses. Similarly for the East Asia clade, 
we specified priors for the age of the whole dataset (60 +/− 10 kya) and for the individual 
haplogroups as described in the literature (B4a1: 11 +/− 3 kya; E1a: 9 +/− 3 kya; E1b: 6 +/− 
3 kya)18. For a detailed description of the models and the statistical comparison of skyline 
plots see Supplementary Notes.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Genome-based phylogeny of MTBC mirrors that of human mitochondrial genomes
A, Whole-genome phylogeny of 220 strains of Mycobacterium tuberculosis complex 
(MTBC). Support values for the main branches after inference with Neighbour-joining (left) 
and Maximum-likelihood (right) are shown. B, Principal Component Analysis (PCA) of the 
34,167 SNPs. The first three PCA axes are shown; these discriminate between evolutionarily 
“modern” (highlighted in grey) and “ancient” (all other) strains. Individual lineages are 
shown following the colour coding of Fig. 1A. C and D, Comparison of MTBC phylogeny 
(C) and a phylogeny derived from 4,955 mitochondrial genomes representative of the main 
human haplogroups (D). The colour coding highlights the similarities in tree topology and 
geographic distribution of MTBC strains and main human mitochondrial macro-haplogroups 
(black - African clades: MTBC Lineage 5 and 6, human mitochondrial macro-haplogroups 
L0-L3; pink – South-East Asian and Oceanian clades: MTBC Lineage 1, human 
mitochondrial macro-haplogroup M; blue – Eurasian clades: MTBC Lineage 2, 3, and 4, 
human mitochondrial macro-haplogroup N). The MTBC Lineage 7 has only been found in 
Ethiopia and its correlation with any of the three main human haplogroups remains unclear.
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Figure 2. Out-of-Africa and Neolithic expansion of MTBC
A, Map summarizing the results of the phylogeographic and dating analyses of MTBC. The 
colour codes used for lineages are according to Fig. 1A. Major splits are annotated with the 
median value (in kya) of the dating of the relevant node. Lineage 7 (yellow) has so far been 
isolated exclusively from patients with known country of origin in the Horn of Africa14. 
Lineage 7 diverged subsequent to the proposed Out-of-Africa migration of MTBC; it may 
have arisen amongst a human population that remained in Africa, or a population that 
returned to Africa. B, Bayesian skyline plots illustrating changes in population diversity of 
MTBC (red line) and humans based on mitochondrial DNA (blue lines) during the last 60 
ky. Dashed lines represent the 95% highest probability density (HPD) intervals for the 
estimated population sizes.
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Figure 3. Neolithic expansion and spread of MTBC Lineage 2 “Beijing” in East Asia
A, Bayesian skyline indicating changes in Lineage 2 diversity over time (red line) as 
compared to human mtDNA haplogroups from East Asia (blue line). 95% HPD intervals for 
the population size estimations are shown in dashed lines. B, Dated Bayesian phylogeny of 
the MTBC Lineage 2 based on coalescent analysis. C, Map of the parallel origin and 
migration of MTBC and humans in East Asia indicating the first archaeological evidence of 
modern human in the region 32–42 kya, coinciding with the migration of MTBC from 
Central to East Asia, the start of the Neolithic in the region indicated by the first evidence of 
domesticated crop in China coinciding with the origin of the MTBC “Beijing family” 8 kya 
(6–11 kya), and the co-expansion of agriculture and MTBC “Beijing family” into 
neighbouring countries 3–5 kya.
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Figure 4. Time-dependent decay of substitution rates in bacteria based on whole-genome 
datasets
Scatter plot graph representing the relationship between substitution rate and time span 
between the most recent ancestor and the last sampling date for each studied pathogen. 
Values were extracted from relevant publications that use whole-genome representative 
datasets and coalescent analysis of substitution rates (for a complete list of references see 
Supplementary Table 9).
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